Characterization of a new SARS-CoV-2 variant that emerged in Brazil
Imai M., Halfmann PJ., Yamayoshi S., Iwatsuki-Horimoto K., Chiba S., Watanabe T., Nakajima N., Ito M., Kuroda M., Kiso M., Maemura T., Takahashi K., Loeber S., Hatta M., Koga M., Nagai H., Yamamoto S., Saito M., Adachi E., Akasaka O., Nakamura M., Nakachi I., Ogura T., Baba R., Fujita K., Ochi J., Mitamura K., Kato H., Nakajima H., Yagi K., Hattori S-I., Maeda K., Suzuki T., Miyazato Y., Valdez R., Gherasim C., Furusawa Y., Okuda M., Ujie M., Lopes TJS., Yasuhara A., Ueki H., Sakai-Tagawa Y., Eisfeld AJ., Baczenas JJ., Baker DA., O’Connor SL., O’Connor DH., Fukushi S., Fujimoto T., Kuroda Y., Gordon A., Maeda K., Ohmagari N., Sugaya N., Yotsuyanagi H., Mitsuya H., Suzuki T., Kawaoka Y.
Significance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are of concern, with the P.1 variants dominating in Brazil. Brazil is now seeing a record number of deaths. Here, we report that the pathogenicity in hamsters of a P.1 variant is similar to that of nonvariant SARS-CoV-2. However, it has an expanded host range as shown by its replication in mice. Prior infection with nonvariant SARS-CoV-2 strains efficiently prevented replication of the P.1 variant in the lower respiratory tract of hamsters upon reinfection. Convalescent sera from patients infected with nonvariants or sera from messenger RNA vaccinees showed comparable neutralization titers among the P.1 and previously circulating strains. These results suggest that previous SARS-CoV-2 infection and vaccines based on the original SARS-CoV-2 will provide some protection against P.1 infection.